EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 4.0

Longitudinal Progression of Patients with Long COVID Treated in a Post-COVID Clinic: A Cross-Sectional Survey

Ryan T Hurt, Siddhant Yadav, Darrell R Schroeder, Ivana T Croghan iD, Michael R Mueller, Stephanie L Grach iD, Christopher A Aakre, Elizabeth A Gilman, Christopher R Stephenson, Joshua Overgaard, Nerissa M Collins, Donna K Lawson und 4 weitere

Journal of Primary Care & Community Health · 2024-01 · 15

DOI: 10.1177/21501319241258671 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Primary Care & Community Health, online erschienen am 30.05.2024. Verfasst von Ryan T Hurt und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: COVID-19, Post-Acute COVID-19 Syndrome. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, GHR Foundation, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In addition to the morbidity and mortality associated with acute infection, COVID-19 has been associated with persistent symptoms (>30 days), often referred to as Long COVID (LC). LC symptoms often cluster into phenotypes, resembling conditions such as fibromyalgia, postural orthostatic tachycardiac syndrome (POTS), and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). LC clinics have been established to best address the needs of LC patients and continuity of care. We developed a cross-sectional survey to assess treatment response through our LC Clinic (LCC).

Methods

A 25-question survey (1-10 Likert scale) was expert- and content-validated by LCC clinicians, patients, and patient advocates. The survey assessed LC symptoms and the helpfulness of different interventions, including medications and supplements. A total of 852 LCC patients were asked to complete the survey, with 536 (62.9%) responding.

Results

The mean time from associated COVID-19 infection to survey completion was 23.2 ± 6.4 months. The mean age of responders was 52.3 ± 14.1 (63% females). Self-reported symptoms were all significantly improved ( P < .001) from the initial visit to the LCC (baseline) to the time of the follow-up survey. However, only 4.5% (24/536) of patients rated all symptoms low (1-2) at the time of the survey, indicating low levels of full recovery in our cohort. The patients rated numerous interventions as being helpful, including low-dose naltrexone (45/77; 58%), vagal nerve stimulation (18/34; 53%), and fisetin (28/44; 64%).

Conclusions

Patients report general improvements in symptoms following the initial LCC visit, but complete recovery rates remain low at 23.2 ± 6.4 months.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Post-Acute COVID-19 SyndromeHumansCross-Sectional StudiesMiddle AgedFemaleMaleAdultSurveys and QuestionnairesLongitudinal StudiesDisease ProgressionSARS-CoV-2Aged

Stichwörter der Autor:innen

ME-CFSlong COVIDmyalgic encephalomeylitisorthostatic tachycardiac syndromepost-COVID

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Department of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
  • Department of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.
  • Division of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Department of Internal Medicine, Division of Hospital Internal Medicine, Mayo Clinic, Rochester, MN, USA.

ORCID-Profile: Ivana T Croghan, Stephanie L Grach, Ravindra Ganesh

Förderung

  • NCATS NIH HHS
  • GHR Foundation
  • National Center for Advancing Translational Sciences

Zitieren

APA

Hurt, R. T., Yadav, S., Schroeder, D. R., Croghan, I. T., Mueller, M. R., Grach, S. L., Aakre, C. A., Gilman, E. A., Stephenson, C. R., Overgaard, J., Collins, N. M., Lawson, D. K., Thompson, A. M., Natividad, L. T., Mohamed Elfadil, O., & Ganesh, R. (2024). Longitudinal Progression of Patients with Long COVID Treated in a Post-COVID Clinic: A Cross-Sectional Survey. Journal of Primary Care & Community Health, 15. https://doi.org/10.1177/21501319241258671

Vancouver

Hurt RT, Yadav S, Schroeder DR, Croghan IT, Mueller MR, Grach SL, et al. Longitudinal Progression of Patients with Long COVID Treated in a Post-COVID Clinic: A Cross-Sectional Survey. Journal of Primary Care & Community Health. 2024;15. doi:10.1177/21501319241258671

BibTeX
@article{Hurt2024,
  author = {Hurt, Ryan T and Yadav, Siddhant and Schroeder, Darrell R and Croghan, Ivana T and Mueller, Michael R and Grach, Stephanie L and Aakre, Christopher A and Gilman, Elizabeth A and Stephenson, Christopher R and Overgaard, Joshua and Collins, Nerissa M and Lawson, Donna K and Thompson, Ann M and Natividad, Lasonya T and Mohamed Elfadil, Osman and Ganesh, Ravindra},
  title = {Longitudinal Progression of Patients with Long COVID Treated in a Post-COVID Clinic: A Cross-Sectional Survey},
  journal = {Journal of Primary Care & Community Health},
  year = {2024},
  volume = {15},
  doi = {10.1177/21501319241258671}
}
Kostenlos starten →